Fertility experts urge UK to adopt new DNA screening for IVF embryos
By Nicola Davis,
The Guardian
| 07. 04. 2016
A new technique to genetically screen IVF embryos should be considered for use in the UK, fertility experts say. The call comes after research revealed it could help doctors select embryos that have the best of chance of leading to a pregnancy.
Pre-implantation genetic screening (PGS) is more common in the US than the UK, and is used by doctors to flag up embryos with an abnormal number of chromosomes - the main reason why embryos fail to implant in the womb.
But other factors also affect whether an embryo will implant: around a third of embryos with the correct number of chromosomes also fail to lead to a pregnancy when transferred to the womb.
Intriguingly, scientists have recently found that many of these apparently healthy embryos have something in common: they have increased levels of the DNA that is found within mitochondria - the tiny energy-generating structures that sit inside cells. The discovery, scientists say, offers a new tool for genetically screening embryos with the technique, known as mitochondrial DNA quantification, recently made available in the US.
Now fertility...
Related Articles
By Carly Mallenbaum, Axios [cites Emily Galpern] | 03.29.2026
More Americans are turning to surrogacy to build their families, as the practice becomes more common and more publicly discussed.
Why it matters: As surrogacy becomes more visible and accessible, ethical, legal and cultural tensions become harder to ignore...
By Carly Mallenbaum, Axios [cites Surrogacy360] | 03.29.2026
Without a federal law, surrogacy in the U.S. is governed by a patchwork of state regulations/
Why it matters: Confusing, varied local rules can determine everything from whether agreements are legally binding to who is recognized as a parent at...
By David Jensen, The California Stem Cell Report | 03.26.2026
SACRAMENTO, Ca. -- California’s $12 billion stem cell and gene therapy program scored a historic first today, announcing that it had for the first time helped to finance a revolutionary treatment that will now be available to the general public...
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...